Patents by Inventor Ana Aguilera Barreto

Ana Aguilera Barreto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations for the rectal administration of thrombolytically-active agents
    Patent number: 10213379
    Abstract: Pharmaceutical formulations in suppository form, containing thrombolytic agents, which are able to penetrate rectal mucous, for the treatment of acute hemorrhoid diseases and/or diseases of thrombotic origin.
    Type: Grant
    Filed: December 22, 2003
    Date of Patent: February 26, 2019
    Assignee: CENTRO DE INGENIERIA GENETICA Y BIOTECHNOLOGIA
    Inventors: Maria Acelia Marrero Miragaya, Ana Aguilera Barreto, Lisette Gonzalez Chavez, Eduardo Martinez Diaz, Beatriz Torrez Cabrera, Karelia Cosme Diaz, Luciano Francisco Hernandez Marrero, Beatriz Tamargo Santos
  • Orally administrable pharmaceutical pellet of epidermal growth factor
    Patent number: 9205130
    Abstract: The present invention comprises a pellet of epidermal growth factor and methionine or K2S2O7, a capsule which comprises these pellets, processes for theirs preparations and it use for the treatment of ulcerative colitis.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: December 8, 2015
    Assignees: CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA, BIOREC S.A.
    Inventors: Raimundo Ubieta Gómez, Ana Aguilera Barreto, Eduardo Martínez Díaz, Rolando Paez Meireles, Antonio Sereno Guerra
  • Stabilized pharmaceutical formulations that contain the interferons gammas and alpha in synergistic proportions
    Patent number: 8535657
    Abstract: The present invention is related to stable pharmaceutical formulations to be applied by parenteral (liquids or freeze-dried), or topic way (gel, unguent or cream) that contain different quantities of the recombinant interferons gamma and alpha in synergistic proportions for the treatment of pathological events that contemplate the malignant or benign not-physiological growth of cells in tissue or organs.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: September 17, 2013
    Assignee: Centro de Ingenieria Genetica y Biotecnologia
    Inventors: Iraldo Bello Rivero, Pedro Lopez Saura, Yanelda Garcia Vega, Hector Santana Milian, Ana Aguilera Barreto, Rolando Paez Meireles, Lorenzo Anasagasti Angulo
  • ORALLY ADMINISTRABLE PHARMACEUTICAL PELLET OF EPIDERMAL GROWTH FACTOR
    Publication number: 20120308661
    Abstract: The present invention comprises a pellet of epidermal growth factor and methionine or K2S2O7, a capsule which comprises these pellets, processes for theirs preparations and it use for the treatment of ulcerative colitis.
    Type: Application
    Filed: February 10, 2011
    Publication date: December 6, 2012
    Applicants: BIOREC S. A., CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
    Inventors: Raimundo Ubieta Gómez, Ana Aguilera Barreto, Eduardo Martínez Díaz, Rolando Paez Meireles, Antonio Sereno Guerra
  • STABILIZED PHARMACEUTICAL FORMULATIONS THAT CONTAIN THE INTERFERONS GAMMA AND ALPHA IN SYNERGISTIC PROPORTIONS
    Publication number: 20090304628
    Abstract: The present invention is related to stable pharmaceutical formulations to be applied by parenteral (liquids or freeze-dried), or topic way (gel, unguent or cream) that contain different quantities of the recombinant interferons gamma and alpha in synergistic proportions for the treatment of pathological events that contemplate the malignant or benign not-physiological growth of cells in tissue or organs.
    Type: Application
    Filed: October 27, 2006
    Publication date: December 10, 2009
    Inventors: Iraldo Bello Rivero, Pedro López Saura, Yanelda Garcia Vega, Héctor Santana Milian, Ana Aguilera Barreto, Rolando Pâez Meireles, Lorenzo Anasagasti Angulo